《生命科学》 2022, 34(8): 974-982

从战略规划与科技布局看国内外人工智能医学应用的发展现状

袁天蔚¹ , 薛　淮² , 杨　靖³ , 张英梅⁴ , 熊　燕¹ , 阮梅花^1,*

¹中国科学院上海营养与健康研究所，中国科学院上海生命科学信息中心，上海 200031 ²中国科学 院学部工作局，北京 100190 ³复旦大学附属中山医院徐汇医院心内科，上海互联网医院工程技术研究 中心，上海 200031 ⁴复旦大学附属中山医院心内科，上海市心血管病研究所，上海 200032

摘　要：

人工智能技术适用于各类医学场景，能够优化并提高医学研究和医疗服务效率。该文总结了美国、欧洲、日本、中国在人工智能医学应用方面的战略规划、科技项目和支撑平台，结合论文和专利的产出情况，比较主要国家在人工智能医学应用领域的发展现状。我国的人工智能医学应用论文和专利数量已经位列全球第一，但尚未明确优先领域发展路径，跨模态数据资源和学科交叉型人才未获得充分关注，行业标准和监管体系有待进一步完善。为推动我国人工智能在医学应用中的发展，建议优化健康与医学数据平台等医疗信息基础设施，聚焦重点应用领域开展技术攻关，培养学科交叉型人才，加快相关标准体系建设。

通讯作者：阮梅花 , Email:mhruan@sibs.ac.cn

Development status of artificial intelligence in medicine based on the strategic planning and scientific projects

YUAN Tian-Wei¹ , XUE Huai² , YANG Jing³ , ZHANG Ying-Mei⁴ , XIONG Yan¹ , RUAN Mei-Hua^1,*

¹Shanghai Information Center for Life Sciences, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 200031, China ²Academic Divisions, Chinese Academy of Sciences, Beijing 100190, China ³Department of Cardiology, Shanghai Xuhui District Central Hospital and Zhongshan-Xuhui Hospital, Fudan University, Shanghai Internet Hospital Engineering Technology Research Center, Shanghai 200031, China ⁴Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China

Abstract:

Artificial intelligence can optimize the efficiency and quality of research and services in various medical scenarios. This paper summarizes the strategic planning, scientific projects and supporting platforms of artificial intelligence in medicine in the United States, Europe, Japan and China. In combination with the output of research articles and patents, it compares the development status of artificial intelligence in medicine. In China, the number of research articles and patents of artificial intelligence in medicine has ranked first all over the world in 2021. However, the roadmaps of priority areas in China have not been clarified yet. Cross modal databases and interdisciplinary talents have not received sufficient attention. The industrial standards and regulatory systems need to be further improved. In order to promote the development of artificial intelligence in medicine in China, this paper makes the following suggestions: optimizing the health and medical information infrastructure, carrying out projects in priority areas, cultivating interdisciplinary talents in medicine and artificial intelligence, and accelerating the construction of relevant standard systems.

Communication Author：RUAN Mei-Hua , Email:mhruan@sibs.ac.cn